《2011NICE肺癌诊治指南》内容简介:
Since publication of NICE clinical guideline 24 in 2005, a number of newsystemic therapies have been granted a marketing authorisation by theEuropean Medicines Agency for use in people with NSCLC. NICE haspublished technology appraisals for pemetrexed, gefitinib and erlotinib. Othertechnology appraisals are in development.
《2011NICE肺癌诊治指南》内容预览:
This guidance updates and replaces NICE clinical guideline 24 (publishedFebruary 2005)。
New and updated recommendations are included on communication,diagnosis and staging, selection of patients with non-small-cell lung cancer(NSCLC) for treatment with curative intent, surgery with curative intent forNSCLC, smoking cessation, combination treatment for NSCLC, treatment forsmall-cell lung cancer (SCLC), managing endobronchial obstruction,managing brain metastases, and follow-up and patient perspectives.
点击下载***:《2011NICE肺癌诊治指南》
本共识意见(草案)依据我国胰腺囊性肿瘤的最近研究,并参考国际相关指南和研究...[详细]
在美国,结直肠癌发病率占所有癌症的第四位,而死亡率为第二位。2012年估计...[详细]